Your browser doesn't support javascript.
loading
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi, Ryosuke; Tsugawa, Sakiko; Noda, Yoshihiro; Plitman, Eric; Honda, Shiori; Matsushita, Karin; Chavez, Sofia; Sawada, Kyosuke; Wada, Masataka; Matsui, Mie; Fujii, Shinya; Miyazaki, Takahiro; Chakravarty, M Mallar; Uchida, Hiroyuki; Remington, Gary; Graff-Guerrero, Ariel; Mimura, Masaru; Nakajima, Shinichiro.
Afiliação
  • Tarumi R; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Tsugawa S; Department of Psychiatry, Komagino Hospital, Hachioji, Japan.
  • Noda Y; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Plitman E; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Honda S; Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Matsushita K; Department of Psychiatry, McGill University, Montreal, QC, Canada.
  • Chavez S; Graduate School of Media and Governance, Keio University, Tokyo, Japan.
  • Sawada K; Faculty of Environment and Information Studies, Keio University, Tokyo, Japan.
  • Wada M; Campbell Institute Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Matsui M; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Fujii S; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Miyazaki T; Department of Clinical Cognitive Neuroscience, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan.
  • Chakravarty MM; Faculty of Environment and Information Studies, Keio University, Tokyo, Japan.
  • Uchida H; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
  • Remington G; Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Graff-Guerrero A; Department of Psychiatry, McGill University, Montreal, QC, Canada.
  • Mimura M; Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.
  • Nakajima S; Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
Neuropsychopharmacology ; 45(4): 632-640, 2020 03.
Article em En | MEDLINE | ID: mdl-31842203
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Índice de Gravidade de Doença / Ácido Glutâmico / Espectroscopia de Prótons por Ressonância Magnética Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Índice de Gravidade de Doença / Ácido Glutâmico / Espectroscopia de Prótons por Ressonância Magnética Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article